Owens & Minor - OMI Stock Forecast, Price & News

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

Owens & Minor Stock Up 4.5 %

Shares of Owens & Minor stock traded up $1.48 during trading on Monday, reaching $34.19. 748,870 shares of the company traded hands, compared to its average volume of 785,629. The company has a debt-to-equity ratio of 2.68, a current ratio of 1.55 and a quick ratio of 0.58. Owens & Minor has a 1-year low of $29.50 and a 1-year high of $49.11. The company has a 50 day moving average price of $32.97 and a 200-day moving average price of $37.92. The firm has a market capitalization of $2.60 billion, a PE ratio of 17.01, a P/E/G ratio of 1.32 and a beta of 0.55.

Owens & Minor (NYSE:OMI - Get Rating) last released its earnings results on Wednesday, August 3rd. The company reported $0.76 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.76. Owens & Minor had a net margin of 1.56% and a return on equity of 26.66%. The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.53 billion. During the same quarter in the previous year, the company earned $1.06 EPS. Owens & Minor's quarterly revenue was up .4% compared to the same quarter last year. As a group, equities research analysts expect that Owens & Minor will post 3.19 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on OMI shares. StockNews.com downgraded Owens & Minor from a "buy" rating to a "hold" rating in a research report on Wednesday, May 11th. Robert W. Baird dropped their price target on Owens & Minor from $70.00 to $62.00 and set an "outperform" rating on the stock in a research note on Thursday. Citigroup reduced their price objective on shares of Owens & Minor from $58.00 to $52.00 in a research report on Thursday. Finally, Credit Suisse Group dropped their target price on shares of Owens & Minor from $43.00 to $37.00 and set a "neutral" rating on the stock in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $50.33.

Insiders Place Their Bets

In other Owens & Minor news, Director Gwendolyn M. Bingham sold 7,600 shares of the company's stock in a transaction on Thursday, May 12th. The shares were sold at an average price of $35.32, for a total transaction of $268,432.00. Following the transaction, the director now owns 22,184 shares in the company, valued at $783,538.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, COO Jeffrey T. Jochims sold 8,000 shares of the stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $31.31, for a total value of $250,480.00. Following the completion of the sale, the chief operating officer now owns 195,956 shares in the company, valued at $6,135,382.36. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gwendolyn M. Bingham sold 7,600 shares of the stock in a transaction dated Thursday, May 12th. The shares were sold at an average price of $35.32, for a total transaction of $268,432.00. Following the completion of the sale, the director now owns 22,184 shares of the company's stock, valued at approximately $783,538.88. The disclosure for this sale can be found here. Corporate insiders own 4.09% of the company's stock.